课题基金 / 基金详情

In Vitro And In Vivo Screening of chemopreventive agents

In Vitro And In Vivo Screening of chemopreventive agents
化学预防剂的体外和体内筛选
批准号:
8151535
负责人:
DAVID MCCORMICK
金额:
$104.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-30 至 2011-04-29

项目摘要

项目成果

DAVID MCCORMICK的其他基金

相似基金

相关文献

中文摘要
翻译
本主协议提案旨在建立和确定最有效的化学预防剂和条件,将抑制,逆转或延迟癌症。该主协议提案下的工作是与癌症预防司(DCP)的NCI协调进行的,使用最先进的机制模型,以便了解人类癌症预防和控制。 该提案将在基于机制的体外和体内试验中筛选和鉴定潜在的癌症预防剂。
英文摘要
This Master Agreement proposal is designed to establish and identify the most proficent chemopreventive agent and conditions that will inhibit, reverse or delay cancer. The work under this master agreement proposal is carried out in coordination with the NCI, in the Division of Cancer Prevention (DCP), using state of the art , mechanism-based models, such that insight may be gained about cancer prevention and control in man. The proposal will provide screening and identification of potential cancer preventive agents in mechanism-based in vitro and in vivo assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
  • 批准号:
    10932479
  • 项目类别:
  • 资助金额:
    $65.95万
  • 财政年份:
    2023
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
CONTRACT ORIENTATION & KICKOFF MEETING FOR R&D SERVICES UNDER "PRECLINICAL TOXICOLOGY OF SMALL MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIO
  • 批准号:
    10710462
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2022
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
  • 批准号:
    10802090
  • 项目类别:
  • 资助金额:
    $145.68万
  • 财政年份:
    2022
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS
  • 批准号:
    10605054
  • 项目类别:
  • 资助金额:
    $75.0万
  • 财政年份:
    2022
  • 负责人:
    DAVID MCCORMICK
  • 依托单位:
海外基金